132 related articles for article (PubMed ID: 20864384)
1. Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future.
Giske CG; Cornaglia G;
Drug Resist Updat; 2010; 13(4-5):93-8. PubMed ID: 20864384
[TBL] [Abstract][Full Text] [Related]
2. The importance and future of antimicrobial surveillance studies.
Masterton R
Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.
Blomberg B; Mwakagile DS; Urassa WK; Maselle SY; Mashurano M; Digranes A; Harthug S; Langeland N
BMC Public Health; 2004 Oct; 4():45. PubMed ID: 15476559
[TBL] [Abstract][Full Text] [Related]
4. European recommendations for antimicrobial resistance surveillance.
Cornaglia G; Hryniewicz W; Jarlier V; Kahlmeter G; Mittermayer H; Stratchounski L; Baquero F;
Clin Microbiol Infect; 2004 Apr; 10(4):349-83. PubMed ID: 15059129
[TBL] [Abstract][Full Text] [Related]
5. Optimal use of antibiotic resistance surveillance systems.
Critchley IA; Karlowsky JA
Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
[TBL] [Abstract][Full Text] [Related]
6. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
[TBL] [Abstract][Full Text] [Related]
7. The Alexander Project: the benefits from a decade of surveillance.
Felmingham D; White AR; Jacobs MR; Appelbaum PC; Poupard J; Miller LA; Grüneberg RN
J Antimicrob Chemother; 2005 Oct; 56 Suppl 2():ii3-ii21. PubMed ID: 16282278
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program.
Deshpande LM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Aug; 49(4):231-6. PubMed ID: 15313526
[TBL] [Abstract][Full Text] [Related]
9. Surveillance uncovers the smoking gun for resistance emergence.
Verhoef J; Fluit A
Biochem Pharmacol; 2006 Mar; 71(7):1036-41. PubMed ID: 16288993
[TBL] [Abstract][Full Text] [Related]
10. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
Møller JK
Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects.
Holloway K; Mathai E; Gray A;
Trop Med Int Health; 2011 Mar; 16(3):368-74. PubMed ID: 21138508
[TBL] [Abstract][Full Text] [Related]
12. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
Fedler KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of antimicrobial resistance among food animals: principles and limitations.
Aarestrup FM
J Vet Med B Infect Dis Vet Public Health; 2004; 51(8-9):380-8. PubMed ID: 15525370
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological interpretation of antibiotic resistance studies - what are we missing?
Schwaber MJ; De-Medina T; Carmeli Y
Nat Rev Microbiol; 2004 Dec; 2(12):979-83. PubMed ID: 15550943
[TBL] [Abstract][Full Text] [Related]
16. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
Bertrand X; Costa Y; Pina P
Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
[TBL] [Abstract][Full Text] [Related]
17. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
Anderegg TR; Sader HS; Fritsche TR; Ross JE; Jones RN
Int J Antimicrob Agents; 2005 Jul; 26(1):13-21. PubMed ID: 15967640
[TBL] [Abstract][Full Text] [Related]
18. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000.
McDonald LC; Lauderdale TL; Shiau YR; Chen PC; Lai JF; Wang HY; Ho M;
Int J Antimicrob Agents; 2004 Apr; 23(4):362-70. PubMed ID: 15081085
[TBL] [Abstract][Full Text] [Related]
19. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).
Draghi DC; Jones ME; Sahm DF; Tillotson GS
Int J Antimicrob Agents; 2006 Dec; 28(6):525-31. PubMed ID: 17101260
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
